Results 211 to 220 of about 56,778 (348)

Diagnosis and Management of Stevens‐Johnson Syndrome and Toxic Epidermal Necrolysis in Pediatric Patients: A Systematic Review of Clinical Guidelines and Consensus Statements

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT Stevens‐Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare, life‐threatening mucocutaneous reactions. Pediatric mortality is lower than in adults, but children face higher risks of recurrence and long‐term sequelae. Despite disease severity, pediatric‐specific guidelines remain scarce and often extrapolated from adult ...
Rachel Creighton   +3 more
wiley   +1 more source

The Inpatient Burden of Pediatric Dermatology in the United States: A National Analysis of the 2022 Kids' Inpatient Database

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT Background Dermatologic conditions are a significant reason for pediatric hospitalizations in the United States. A prior analysis of the 2012 Kids' Inpatient Database (KID) established a national benchmark for this burden, but changes in medical coding, healthcare delivery, and demographics necessitate an updated assessment.
Shiv Patel   +3 more
wiley   +1 more source

Autoimmune sequelae in severe drug eruptions [PDF]

open access: yesClin Transl Allergy, 2014
Aoyama Y   +7 more
europepmc   +1 more source

Progressive Linear Bullous Eruption in a Young Athlete: A Diagnostic Challenge

open access: yes
Journal of Paediatrics and Child Health, EarlyView.
Chon‐Wai Jeremy Chan   +4 more
wiley   +1 more source

Dermatologic Findings of RELA‐Associated Autoinflammatory Disease

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT Variants in the gene RELA have been implicated in a monogenic, hereditary form of Behcet's‐like syndrome. This case series describes the dermatologic manifestations of three patients with identified RELA‐associated autoinflammatory disease.
Elizabeth Nourse   +4 more
wiley   +1 more source

A case of drug‐induced Stevens‐Johnson syndrome‐like eruption predominating in mucosa: A case report

open access: gold, 2020
Akihiro Ishiguro   +6 more
openalex   +1 more source

Setmelanotide in Bardet‐Biedl Syndrome: A Case Report

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT Setmelanotide is a melanocortin‐4‐receptor agonist used for the treatment of hyperphagia in the genetic obesity syndrome Bardet‐Biedl. Presented is a case of diffuse hyperpigmentation in a patient treated with setmelanotide, which represents the most common side effect of this medication.
Shelby Smith   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy